• Recruiting

NCT04937777: EMN 23 - Study on the Management & Outcome of Systemic AL Amyloidosis in Europe

EMN 23

NCT04937777: A Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe

EMN23 AMYLOIDOSIS

NCT04937777: A Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe


This is a retrospective, observational, multicenter study to collect Real-World Evidence (RWE) data on systemic AL-AMY patients in Europe. Data from paper/electronic medical records and/or electronic databases from key reference centers in Europe will be used. Data will either be entered by the site staff in the electronic Case Report Form (eCRF) or, where feasible, transferred directly, always in accordance to local regulations.


Sponsor

European Myeloma Network

 

ClinicalTrials.gov Identifier: NCT04937777

Official Title: A Retrospective Observational Multicenter Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe

First Posted : June 24, 2021

Click here to see details on ClinicalTrials.gov


EMN23 - European Myeloma Network (myeloma-europe.org)

 

Locations

Europe

United Kingdom

Austria

Czechia

France

Germany

Greece

Italy

Netherlands

Portugal

Spain



Posts Archive